The analyst measures the quantitative level of total alpha–1–antitrypsin. Providers order the test primarily to detect the hereditary decrease of this analyte. Providers use alpha–1–antrypsin measurement levels as an indicator of chronic obstructive lung disease. Serum or plasma is the specimen of choice.
For clinical responsibility, terminology, tips and additional info
start codify free trial.